Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Core Income Taxes: -$3,366M in FY2025, up 11.6% from a year earlier.
Latest, FY2025
-3,366
Period ended Dec 31, 2025
Change on a year earlier
+11.6%
-3,016 in FY2024
History
6 years
Since FY2020
Sources
5
Documents cited below
Where the FY2025 figure comes from
“|| Income taxes 5 | -2 385 | -631 | -90 | -8 | -252 | -3 366 | -3 016”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Core Income Taxes ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -3,366 | +11.6% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | -3,016 | +1,101.6% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2023 | Dec 31, 2023 | -251 | -41.8% | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2022 | Dec 31, 2022 | -431 | -83.6% | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2021 | Dec 31, 2021 | -2,635 | +9.7% | Novartis Form 6-K (0001370368-23-000008) ↗ |
| FY2020 | Dec 31, 2020 | -2,403 | – | Novartis Form 6-K (0001370368-22-000009) ↗ |
Cite this data
StockData. (2026). Novartis Core Income Taxes ($M), annual FY2020–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/core-income-taxes
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.